Written question AQW 54398/22-27
Written question by Mr Stephen Dunne on .
- MLA
- Mr Stephen Dunne
- Party at the time
- Democratic Unionist Party
- Date
- 12 October 2026
- Type
- Written question
- Assembly reference
- AQW 54398/22-27
- Department
- Department of Health
- Business
- To the Minister of Health
- Assembly identifier
- Document 503763
Read the official Assembly record Open Data source
Text
To ask the Minister of Health to detail (i) the number of patients in Northern Ireland that have been diagnosed with Grade three and Grade four isocitrate dehydrogenase-mutant gliomas, in each of the last five years; (ii) any assessment that has been made of the potential benefits of Vorasidenib for such patients; and (iii) whether any discussions have taken place regarding extending access to Vorasidenib beyond those currently eligible for treatment.
71 words. Text as published by the Northern Ireland Assembly.
Assessment
Awaiting analysis
This record has not been analysed yet. It is not counted in any total until it has been assessed.
Disagree with this assessment?
Classifications can be challenged. A person reviews every challenge, and any change is recorded publicly above with its reason.